One sec…
One sec…
Tikun Olam high-CBD sativa — near-zero THC.
Avi-Dekel is a Tikun Olam (Israeli medical breeder) sativa-dominant strain built for high CBD with almost no THC — typically 0.5–1% THC alongside 13–16% CBD. Effectively non-psychoactive. One of the earliest CBD-dominant strains developed for medical-program use. Customers reach for it when they want CBD content without measurable lift.
Genetics
Avi-Dekel's parents, descendants, and sister strains in the catalog.
Aromatic chemistry
An Israeli medical-cannabis breeder/research group, one of the earliest formal medical-cannabis programs globally. Avi-Dekel is one of their flagship CBD-dominant strains, developed for medical-program patients.
Both are CBD-dominant, very-low-THC strains. ACDC traces to Cannatonic lineage and the US CBD-genetics scene; Avi-Dekel comes through Tikun Olam's Israeli medical program. Similar effect profile — near-zero psychoactive lift.
Avi-Dekel is a sativa — head-up and uplifted in character, with the energetic profile customers expect from sativa-dominant flower. The lineage is Tikun Olam proprietary selection (parents not publicly disclosed).
Avi-Dekel hits earth up front, light citrus through the middle, and pine on the exhale. The smell out of the jar reads the same way — distinctive once you've had it once or twice.
Avi-Dekel tests in the <1% THC range — on the lower end for a flower strain. Customers report a milder, easier experience than the 24%+ heavy hitters.
Avi-Dekel reads as a daytime strain — head-up and uplifted, the kind customers commonly reach for in the morning or early afternoon when there's still a to-do list.
Verified May 16, 2026 against 2 sources.
21+. Cannabis affects people differently — your experience may vary. Not medical advice. Effects described are common customer reports, not promises. Seattle Cannabis Co., Seattle, WA.